Differentiation of Human Embryonic Stem Cells into Clinically Amenable Keratinocytes in an Autogenic Environment  by Kidwai, Fahad K. et al.
Differentiation of Human Embryonic Stem Cells into
Clinically Amenable Keratinocytes in an Autogenic
Environment
Fahad K. Kidwai1, Hua Liu1,2, Wei Seong Toh1,7, Xin Fu1,3, Doorgesh S. Jokhun4, Mohammad M. Movahednia1,
Mingming Li1, Yu Zou1, Christopher A. Squier5, Toan T. Phan6 and Tong Cao1
Human embryonic stem cells (hESCs)-derived keratinocytes hold great clinical and research potential. However,
the current techniques are hampered by the use of xenogenic components that limits their clinical application.
Here we demonstrated an efficient differentiation of H9 hESCs (H9-hESCs) into keratinocytes (H9-Kert) with the
minimum use of animal-derived materials. For differentiation, we established two microenvironment systems
originated from H9-hESCs (autogenic microenvironment). These autogenic microenvironment systems consist of
an autogenic coculture system (ACC) and an autogenic feeder-free system (AFF). In addition, we showed a stage-
specific effect of Activin in promoting keratinocyte differentiation from H9-hESCs while repressing the
expression of early neural markers in the ACC system. Furthermore, we also explained the effect of Activin in
construction of the AFF system made up of extracellular matrix similar to basement membrane extracted from
H9-hESC-derived fibroblasts. H9-Kert differentiated in both systems expressed keratinocyte markers at mRNA and
protein levels. H9-Kert were also able to undergo terminal differentiation in high Ca2þ medium. These findings
support the transition toward the establishment of an animal-free microenvironment for successful differentia-
tion of hESCs into keratinocytes for potential clinical application.
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INTRODUCTION
Skin is one of the largest organs of the body and acts as the
primary barrier between the external environment and the
deeper tissues. However, conditions such as foot ulcers, skin
defects, and massive burns often result in open wounds and
require rapid surgical closure with appropriate materials
(Izumi et al., 2003). Surgical closures with autologous
epidermal grafts are ideal but have several disadvantages
including donor site morbidity, time constraint, and limited
cell yield from primary explanted keratinocytes. Alternatively,
commercially available grafts with allogeneic primary cells
can be used, but because of the immune response of the
patients, these grafts suffer the risks of potential rejection
(Metcalfe and Ferguson, 2007; Lemaıˆtre et al., 2011). For the
last decade, human embryonic stem cells (hESCs) have been
suggested as a substitute cell source for keratinocytes. hESCs
are derived from the inner cell mass of human blastocysts
(Thomson et al., 1998; Reubinoff et al., 2000). They possess
the unique property of unlimited proliferation and differen-
tiation into all types of somatic cells originated from three
germ layers (Thomson et al., 1998). Furthermore, Guenou
et al. in 2009 have reported that keratinocytes derived
from hESCs express low major histocompatibility complex
class I (HLA-ABC) as compared with primary keratino-
cytes. Therefore, hESC-derived keratinocytes have great
potential in regenerative medicine and dentistry as a
limitless cell source for rapid tissue replacement in patient
treatment (Metallo et al., 2007; Guenou et al., 2009; Lemaıˆtre
et al., 2011).
Green et al. pioneered studies of keratinocyte differentiation
from hESCs in 2003. Since then, various groups have reported
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hESCs’ differentiation into keratinocytes (Aberdam 2004;
De Luca et al., 2006; Iuchi et al., 2006; Ji et al., 2006;
Metallo et al., 2008; Guenou et al., 2009; Hewitt et al., 2009).
However, to date, the strategies required for the induction of
hESCs toward the keratinocyte lineage involve the use of
xenogeneic microenvironments such as feeder cells and/or
extracellular matrix (ECM). The presence of these xenogeneic
components in a culture milieu limits the clinical application
of hESCs because of the potential risk of transmission of
animal pathogens and viral or bacterial infections (Cobo et al.,
2005; Sjo¨gren-Jansson et al., 2005; Skottman and Hovatta,
2006; Rajala et al., 2010). Alternatively, it has been shown
that the exposure of hESCs to animal components in culture
systems causes higher expression of immunogenic agents (e.g.,
N-glycolylneuraminic acid and Neu5Ac) into hESCs (Martin
et al., 2005; Heiskanen et al., 2007).
Clearly, there is a need to eradicate or at least minimize the
exposure to xenogeneic components in the differentiation
protocols to enhance the clinical application of hESC-derived
keratinocytes (Mallon et al., 2006). Therefore, in this study, we
aim to minimize the use of animal components in the
differentiation protocol to get a pure and expandable popu-
lation of keratinocytes from hESCs in the autogenic micro-
environment instead of the xenogeneic microenvironment.
RESULTS AND DISCUSSION
Characterization of H9-ebF feeders for the autogenic coculture
system (ACC) system
To achieve our aim, we first differentiated H9-hESCs into
fibroblasts (H9-ebF). The importance of fibroblasts in kerati-
nocyte morphogenesis has been studied by few researchers
(Mackenzie et al., 1993; el-Ghalbzouri et al., 2002; El
Ghalbzouri et al., 2002). H9-ebFs were grown and charac-
terized for 10 passages. The expression of the pluripotency
marker Oct4 was observed from passages 1 to 4 on reverse
transcriptase–PCR electrophoretic gel at 1.5 seconds of UV
exposure (Figure 1a). Therefore, we assumed that a portion of
H9-ebFs at passages 1 to 4 were not fully differentiated and
were inappropriate for setting up the ACC system. However,
passages 5 to 10 were further characterized for the expression
of Vimentin and Prolyl 4-hydroxylase to confirm their fibro-
blastic lineage (Figure 1b).
In addition, it has been shown that fibroblasts are respon-
sible for secreting different growth factors like keratinocyte
growth factor-I, which in particular, has an important role
in keratinocyte morphogenesis (Fusenig et al., 1994; Maas-
Szabowski et al., 1999). Therefore, to further optimize
conditions for keratinocyte differentiation, the expression of
keratinocyte growth factor-I was analyzed from passages 5 to
10 of H9-ebF. The level of keratinocyte growth factor-I was
found to be the highest in H9-ebF-passage 8 (P8) (Figure 1c).
H9-ebF P8 was further characterized for fibronectin
expression, which is normally produced by cultured fibro-
blasts (McKeown-Longo et al., 1984) (Figure 1d). Correspond-
ingly, we found no expression of epithelial precursor marker
K18 and/or epidermal marker K14 in H9-ebF P8 (Figure 1d
and e).
Establishment of the ACC system and medium optimization
For the establishment of the ACC system, H9-hESCs were
cocultured with inactivated H9-ebF P8. H9-hESCs and H9-
ebFs required different culture conditions. Therefore, it was
necessary to optimize the culture milieu suitable for both cell
types. The ACC system was kept in three different medium
conditions for 5 days (F12 and Dulbecco medium), defined
keratinocyte serum-free medium (DSFM), and embryonic stem
cell medium (ES medium, without fibroblast growth factor).
Viability of cocultured cells was tested by 3-(4,5-dimethylthia-
zol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium)-cell viability assay. Viability assay results
showed that only F12 and Dulbecco medium and ES
medium were able to support the ACC system with no
significant difference between them. Correspondingly, we
found significantly less viable cells in the ACC system kept in
DSFM compared with other groups (Figure 2a). Thus, we
selected F12 and Dulbecco medium for keratinocyte differ-
entiation in the ACC system.
Retinoic acid (RA) induces neuroectodermal differentiation of
H9-hESCs in the ACC system
For the induction of keratinocyte differentiation, we used RA
as previously reported (Metallo et al., 2008). It has been
shown previously that RA induces DNp63 expression through
the RA receptor (Schuldiner et al., 2000; Chen and Lohnes,
2005). DNp63 is supposed to be a well-known marker for
epidermal progenitors and an essential transcription factor for
keratinocyte differentiation (Mills et al., 1999; Yang et al.,
1999; McKeon, 2004).
For dose optimization of RA, three different concentrations
(0.1, 0.5, and 1mM) were applied. However, in contrast to the
findings of Metallo et al., our flow cytometry results showed
that application of 0.5mM of RA induces significantly higher
DNp63 (þ ) cells compared with other concentrations of RA in
the ACC system (Figure 2b).
To analyze the temporal effect of RA, the ACC system was
treated with 0.5mM of RA until day 10 and day 20, respec-
tively. Real-time reverse transcriptase–PCR results showed that
the continuous exposure treatment for 20 days resulted in
higher expression of DNp63. However, we also found a
significant increase in the expression of neural markers
(Pax6 and Sox1) (Figure 2c). A possible explanation for the
high neural contamination could be the expression of fibro-
blast growth factors by fibroblasts, which induce neural
differentiation of hESCs through the extracellular signal–
regulated kinase 1/2–poly (ADP-ribose) polymerase 1 pathway
(Yoo et al., 2011). Therefore, it was essential to inhibit
the neural differentiation to increase the purity of
keratinocyte population from H9-hESCs.
Effect of Activin in keratinocyte differentiation in the ACC system
The results described above led us to focus on neural
inhibition. Therefore, in this study, we postulate that Activin,
which is a member of the transforming growth factor-b family,
may be a potent inhibitor of the neural pathways. Previously,
Activin has been used to maintain mouse embryonic stem cell
and hESC pluripotency (Beattie et al., 2005; James et al., 2005;
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Vallier et al., 2005) by inhibition of default neural
differentiation (Camus et al., 2006; Patani et al., 2009).
Therefore, it is of interest to find the effect of dose modu-
lation and temporal applications of Activin on inhibition
of neural differentiation alone, without effecting keratino-
cyte induction. However, the effect of Activin on keratino-
cyte differentiation in the presence of RA has never been
reported.
To analyze the temporal effect, Activin was applied for 3
days at different time points (day 1–day 11) of differentiation.
We observed different effects of Activin when applied at
different time points (Figure 3a and b). The early application of
Activin at day 1 and day 2 inhibits the neuroectodermal
differentiation of H9-hESCs by keeping the cells in a pluripo-
tent state. Interestingly, we found that the application of
Activin at day 3, day 4, day 5, day 6, day 7, and day 8
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Figure 1. Characterization of H9-ebF. (a, b) Qualitative analysis of gene expression profile of (a) pluripotency marker and (b) fibroblast markers. b-Actin was taken
as the loading control and run on a separate gel. (c) Results of ELISA show the KGF-I secretion by P 5–P 10 of H9-ebF. Error bars indicate the mean±SEM (n¼3).
*Po0.05 versus all groups. (d, e) Immunofluorescence staining shows the expression of (d) K18 and fibronectin by H9-ebF passage 8 (scale bar¼ 100mm),
(e) K14 by HaCaT cells–H9-ebF passage 8 in coculture (scale bar¼50mm). b-Act, b-actin; CRL-1486, human embryonic palatal mesenchymal cell line;
DAPI, 4,6-diamidino-2-phenylindole; FAD, F12 and Dulbecco medium; H, H9-ebF; hESC, human embryonic stem cell; H9-ebF, H9-hESC-derived fibroblast;
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synergizes neuroectodermal differentiation, predominantly
neural differentiation. However, the introduction of Activin
at day 9, day 10, and day 11 augments ectodermal differ-
entiation while inhibiting the neural differentiation effect
of RA. The application of Activin at day 9 for a period
of 3 days was found to be the most effective (Figure 3b).
We found no substantial difference within different con-
centrations (10, 25, and 50 ng ml 1) of Activin when
applied at the optimized time point (Figure 3c). Thus, we
were able to get around 85%±4.5 (SE) of DNp63 (þ ) cells
from H9-hESCs at day 20 when treated with 0.5 mM of RAs
for 20 days and 25 ng ml1 of Activin for 3 days (from day 9
to day 11) in the ACC system (Figure 3d). However, the
molecular mechanism of the downstream signaling
pathway for the above mentioned effect requires further
investigation.
Keratinocyte differentiation in the ACC system and
characterization
After optimization of in vitro conditions, H9-hESCs were
differentiated into keratinocytes in the ACC system (H9-
KertACC). H9-KertACC were characterized at different time
points (Figure 4a and b). We observed the higher expression
of primitive epithelial marker K18 until day 20 from the start of
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Figure 2. Optimization of in vitro conditions. (a) 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay results show
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differentiation and then found it to have decreased at later
stages (Figure 4b). Concurrently, epidermal precursor marker
DNp63 and the basal keratinocyte marker of stratified epider-
mis, K14, were found to be increased steadily with time
(Figure 4a and b). These results indicate that H9-hESCs in vitro
follow the same hierarchy of embryonic keratinocyte differ-
entiation. During embryogenesis, the K18 (þ ) cells in primi-
tive epithelium are replaced by DNp63 (þ ) cells. Later, these
progenitor cells give rise to basal keratinocytes (K14 (þ ) and
integrin alpha 6 (þ ) cells) cells of stratified epidermis
(Shalom-Feuerstein et al., 2011). Alternatively, we found the
progressive reduction of neural markers (Sox1, Pax6, and
Nestin) and pluripotency markers (Oct4 and Nanog) during
differentiation (Figure 4b). Characterization of H9-KertACC at
the protein level was done to confirm their keratinocyte
lineage (Figure 4c–e). H9-KertACC were able to undergo
terminal differentiation and expressed suprabasal keratinocyte
markers, such as involucrin and filaggrin in DSFM, supple-
mented with 1.5 mmol l1 of calcium chloride. This suggests
that H9-KertACC possess characteristics of epidermal differen-
tiating keratinocytes (Figure 4f).
In addition, we found that H9-KertACC were able to
maintain the high percentage of K14 (þ ) cells in serum-free
medium (Figure 5a). H9-KertACC were able to propagate for
10 passages without reaching the Hayflick limit (Figure 5b).
However, we found the progressive shortening of telomere
length and telomerase reverse transcriptase expression with
increasing passage numbers (Figure 5c and d). Alternatively,
we found no mouse embryonic fibroblast contamination in
H9-Kert ACC (Figure 5e).
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Recently, Guenou et al. (2009) cocultured hESCs with
mouse NIH 3T3 fibroblast cells for the induction of
keratinocyte differentiation and were able to get 50–55% of
K14 (þ ) cells in 40 days (which subsequently required sorting
to achieve approximately 96% of K14 (þ ) cells). On the other
hand, through our differentiation protocol in the ACC system,
we were able to get 78%±7.5 (SE) of K14 (þ ) cells by day 30
and 495% of K14 (þ ) cells on subsequent culture. Our
protocol does not require cell sorting to get the same
percentage of K14 (þ ) cells as previously reported.
Establishment of the serum-free, feeder-free AFF system for
keratinocyte differentiation
For more clinical relevance, we established an improved,
defined, serum-free and autogenic feeder-free (AFF) system by
extracting basement membrane-like ECM from H9-ebF. ECM
from the basement membrane, which is also referred to as
type IV matrix, mainly consists of collagen type IV, laminin,
and proteoglycan. Basement membrane has an important role
in keratinocyte differentiation (Miner et al., 1997; Fleischmajer
et al., 2000), proliferation, and migration (Pouliot et al., 2002).
Collagen type IV is secreted predominantly by keratinocytes;
however, it has been shown previously that transforming
growth factor-b induces fibroblasts to secrete collagen IV
(Lam et al., 2004). Transforming growth factor-b and Activin
share the same SMAD pathway. Alternatively, Activin was
found to upregulate procollagen expression (cytoplasmic
collagen) of fibroblasts. Subsequently, procollagen undergoes
hydroxylation and glycosylation (post-translational modi-
fication) to form a triple helix and is extruded from the cells
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(Tuan and Nichter, 1998; Niessen et al., 1999; Derynck
and Zhang, 2003; Mukhopadhyay et al., 2007). We
found similar results with H9-ebFs. H9-ebFs were able to
secrete collagen Type IV in ECM substrate when exposed to
crowding molecules like ascorbic acid and dextran sulfate
supplemented with Activin for 3–5 days (Figure 6a). Alterna-
tively, the exposure of H9-ebF to crowding molecules
alone resulted in no collagen Type IV expression in ECM
substrate. In addition, the application of Activin was also
found to have enhanced ECM production from H9-ebF
(Figure 6a and b).
Keratinocyte differentiation in the AFF system (H9-KertAFF)
followed the same hierarchy of keratinocyte marker
expression as H9-KertACC (Figure 6c and d). We were able
to get 89%±5.1 (SE) of K14 (þ ) by day 30 from the start of
differentiation (Figure 6e). We found the AFF system as
efficient as the xenogeneic Matrigel system for keratinocyte
differentiation (Figure 6f). In addition, the immunofluores-
cence staining of H9-KertAFF showed higher expression of K14
and alpha integrin-6. Concurrently, we found substantially less
expression of K18 similar as H9-KertACC (Figure 6g). H9-
KertAFF were able to grow until passage 7.
Recently, Metallo et al. used the xenogenic feeder-free
system (Matrigel) for 6–10 days in a differentiation medium
and then subcultured on gelatin-coated plates to get around
87% K14 (þ ) cells from hESCs by day 30. However, we
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induced differentiation of H9-hESCs on the AFF system and
subcultured on human collagen type IV to obtain similar
results.
Although we were able to differentiate hESCs into kerati-
nocytes with the minimum use of materials from animal
sources, DSFM and the medium used to derive H9-ebF and
ECM were not totally free from animal components. Never-
theless, in our study, we have demonstrated that successful
differentiation of expandable and highly enriched populations
of keratinocytes is possible without using xenogeneic feeders
or ECM. We also described the pivotal role of Activin in
keratinocyte differentiation and in the production of specific
types of ECM from fibroblasts. Therefore, the protocols
described in this study are yet another step in bringing stem
cell–based therapies closer to the clinic.
MATERIALS AND METHODS
Cell culture
H9-hESC lines were cultured and passaged as previously described
(Itskovitz-Eldor et al., 2000). Briefly, H9-hESCs were seeded on to an
inactivated mouse embryonic fibroblast feeder cells in ES medium
(1:1 DMEM/F-12, supplemented by 20% knockout serum replace-
ment, 1% nonessential amino acid, 1 mM L-glutamine, 4 ng ml 1
fibroblast growth factor-2, and 0.1 mM b-mercaptoethanol (Sigma, St
Louis, MO)). The medium was changed every day. All the media and
components were obtained from Invitrogen (Carlsbad, CA) unless
otherwise noted.
Generation of H9-ebF as feeder cells for the ACC system
For the establishment of the ACC system, H9-ebFs were obtained
from H9-hESCs as described previously (Fu et al., 2010). Briefly,
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H9-hESCs colonies were dissociated into clumps by treatment with
1 mg ml 1 collagenase type IV and then transferred to nonadherent
six-well culture plates in embryoid body medium (80% DMEM/F12
and 20% knockout serum replacer, supplemented with 1% non-
essential amino acids, 1mM L-glutamine, and 0.1mM b-mecaptoethanol)
for 5 days. Differentiated embryoid bodies were seeded on 0.1%
gelatin-coated plates in a DMEM–fetal bovine serum (FBS) medium
(high-glucose DMEM (Sigma) supplemented with 10% FBS (Biowest,
Caille, Nuaille)) for 3 weeks. H9-ebFs were inactivated and plated
onto the gelatin-coated 6-well plate of approximately 1.4 105 cells
per well followed by H9-hESCs seeding on the next day. The H9-
hESCs–H9-ebF ACC system was kept in ES medium for 2–3 days
before the start of differentiation (Supplementary Figure S1 online).
Keratinocyte differentiation in the ACC system
For keratinocyte differentiation in the ACC system, ES medium was
replaced by F12 and Dulbecco medium (mixture of 3:1 of DMEM and
Ham’s F12 media supplemented with 50mg ml 1 ascorbic acid
(Sigma), 2% FBS, 5mg ml 1 insulin, 10 ng ml 1 recombinant human
epidermal growth factor, and 0.5mM of RA for 22–25 days. In
addition, 25 ng ml 1 of Activin (catalog # 338-AC, R&D Systems,
Minneapolis, MN) was introduced at day 9 until day 11 (3 days) from
the day of differentiation. After 22–25 days, the differentiated cells
were detached and seeded on human collagen type IV–coated flasks
and kept in DSFM without Activin and RA (Supplementary Figure S2
online).
Extraction of ECM from H9-ebF for the AFF system
The AFF system was established with the modification of our
previously published protocol (Fu et al., 2011). Briefly, H9-ebF cells
were seeded on six-well plates at a density of 2.5 105 per well and
kept overnight in DMEM–FBS medium. Next day, the DMEM–FBS
medium was replaced with Crowding medium (DMEM) supplemen-
ted with 0.5% FBS, 50 mg ml 1 ascorbic acid (Sigma), 100 mg ml 1
of dextran sulfate (Sigma), and 25 ng ml 1 recombinant human
Activin for 3–5 days followed by overnight incubation at  80 1C.
Next day, the plate was thawed at room temperature (RT) and each
well was rinsed with phosphate-buffered saline three times to get rid
of cell debris to establish the AFF system. H9-hESCs were seeded onto
the AFF system in an animal component–free TeSR 2 (StemCell
Technology, Vancouver, BC, Canada) medium for 2–3 days before
the start of differentiation (Supplementary Figure S3 online).
Keratinocyte differentiation in the AFF system
For keratinocyte differentiation of H9-hESCs in the AFF system,
animal-free TeSR 2 medium was replaced by differentiation medium
(DSFM supplemented with 1mM of RA) and applied for 10–12 days.
The differentiated cells were subcultured on human collagen type IV–
coated plates and kept in DSFM without RA.
Keratinocyte cell lines HaCaT were taken as control. Control cell
line was grown in DMEM–FBS medium.
Reverse transcriptase–PCR and real-time PCR analysis
For reverse transcriptase–PCR, cells were subjected to RNA extraction
using the RNeasy Mini Kit (Qiagen, Valencia, CA), following the
manufacturer’s instructions. b-Actin served as a loading control.
For real-time PCR, the reactions were performed using the SYBR
Green PCR Master Mix System (Applied Biosystems, Foster City, CA)
and processed on the StepOnePlus real-time PCR system (Applied
Biosystems). Expression of b-actin was used as the reference gene.
The expression level of each target gene was then calculated as 2DDCt
as described previously (Livak and Schmittgen, 2001). A melting
curve was used to verify the PCR products (Supplementary Table S4
online).
ELISA analysis
ELISA was performed using the DuoSet ELISA Development System
(catalog # DY251, R&D systems) as per the manufacturer’s instruc-
tions. Absorbance of each well was measured at 450 nm.
Western blotting
Cell extracts were prepared in RIPA lysis buffer containing 50 mM
Tris-HCl (pH 8.0), 150 mM sodium chloride, 1.0% Triton X-100,
0.5% sodium deoxycholate, 0.1% SDS, and 1X EDTA-free complete
protease inhibitor cocktail. The sample was centrifuged and the
supernatant was collected. Samples were then boiled for 5 minutes
at 90 1C, electrophoresed on 12% SDS-polyacrylamide gel, and
transferred onto polyvinylidene difluoride membrane. The membrane
was blocked for 1 hour with 5% nonfat dry milk in phosphate-
buffered saline with Tween (0.1% Tween 20) and probed with the
primary antibody (1:1000) (Supplementary Table S5 online) overnight
at 4 1C. Blots were then incubated with peroxidase-conjugated
secondary antibody (1:5000) (Supplementary Table S5 online) for
1 hour at RT, and were developed by enhanced chemiluminescence
(Pierce, Rockford, IL).
Immunofluorescence, confocal microscopy, and flow cytometry
Staining was done as described previously (Yang et al., 2009). Briefly,
samples were fixed for 15 minutes in 4% paraformaldehyde at RT,
permeabilized with 0.4% Triton X-100/phosphate-buffered saline (if
required) for 10 minutes, and blocked with phosphate-buffered saline
containing 4% BSA (Sigma) for 1 hour at RT. The cells were incubated
overnight at 4 1C with the primary antibody (1:100) (Supplementary
Table S5 online). Samples were washed and followed by the
incubation in secondary antibody (1:100) (Supplementary Table S5
online) for 0.5 hours at RT in the dark.
Scanning electron microscope
The samples were fixed in 10% formalin and then dried in
ascending alcohol concentrations. Samples were dehydrated in a
critical point dryer and sputter coated with gold under vacuum and
examined in scanning electron microscope (XL30 FEG SEM, FEI,
Philips, Eindhoven, The Netherlands).
3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium assay
For MTS assay, the CellTiter 96 AQueous One Solution Cell Prolife-
ration Assay Kit (Promega, Southampton, UK) was used as per the
manufacturer’s instructions. Absorbance at 490 nm was recorded.
Telomere length assay
Telomere length assay was performed using the Telo TAGGG
telomere Length Assay Kit (Cat # 12 209 136 001, Roche Diagnostic,
Castle Hill, NSW, Australia) according to the manufacturer’s
instructions.
FK Kidwai et al.
Differentiation of hESCs into Clinically Amenable Keratinocytes
626 Journal of Investigative Dermatology (2013), Volume 133
Statistical analysis
For statistical analysis, one-way analysis of variance post hoc tests
(Tukey and Bonferroni) and Student’s T-test were used. A value of
Po0.05 was considered as significantly different.
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